Activation of the immune system and coronary artery disease: The role of anti-endothelial cell antibodies

Atherosclerosis

Volumn 154, Issue 2, 2001, Pages 429-436

  Farsi, Alessandro ^a   Domeneghetti, Maria Paola ^a   Brunelli, Tamara ^a   Gori, Anna Maria ^a   Fedi, Sandra ^a   Gensini, Gian Franco ^a   Giglioli, Cristina ^a   Prisco, Domenico ^a   Passaleva, Angelo ^a   Meroni, Pier Luigi ^b   Del Papa, Nicoletta ^b   Abbate, Rosanna ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Anti endothelial cell antibodies; Ischaemic heart disease; Percutaneous transluminal coronary angioplasty; Restenosis; Unstable angina

Indexed keywords

BETA2 GLYCOPROTEIN 1; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CROSS REACTION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNE SYSTEM; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; RESTENOSIS; SEROPREVALENCE; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; APOLIPOPROTEINS; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DISEASE PROGRESSION; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FACTOR XA; FEMALE; GLYCOPROTEINS; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; RECURRENCE; THROMBOPLASTIN; UMBILICAL VEINS;

EID: 0035128877     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00482-2     Document Type: Article

References (50)

1. Human antibodies to vascular endothelium
2. Rheumatic disease sera reactive with capillaries in the mouse kidney
3. IgG, and IgM anti-endothelial cell antibodies in patients with collagen vascular disorders
4. Antibodies to endothelial cells in primary vasculitides mediate in vitro endothelial cytotoxicity in the presence of normal peripheral blood mononuclear cells
5. Anti-endothelial cell antibodies in patients with various forms of vasculitis
6. Anti-endothelial cell antibodies: Only for scientists or for clinicians too?
7. Immunological findings in Kawasaki disease: An evaluation in a cohort of Italian children
8. Anti-endothelial antibodies and coronary artery disease after cardiac transplantation
9. Anti-endothelial antibodies after heart transplantation: The accelerating factor in transplant-associated coronary artery disease?
10. Anti-endothelial cell IgG antibodies from patients with Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion
11. IgG anti-endothelial cell antibodies (AECA) in type I diabetes mellitus; induction of adhesion molecule expression in cultured endothelial cells
12. Antibodies to cardiolipin in young survivors of myocardial infarction: An association with recurrent cardiovascular events
13. Anticardiolipin antibodies in ischaemic heart disease
14. Antiphospholipid antibodies and cardiovascular disease
15. Anticardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle aged men
16. Human β2-glycoprotein I binds to endothelial cells through a cluster of lysine residues that are critical for anionic phospholipid binding and offers epitopes for anti-β2 glycoprotein I antibodies
17. Relationship between anti-phospholipid and anti-endothelial cell antibodies III: β2-glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules
18. β2-glycoprotein I as a 'cofactor' for antiphospholipid reactivity with endothelial cells
19. Tissue factor: Then and now
20. Extrinsic pathway inhibitor: The key to feedback control of blood coagulation initiated by tissue thromboplastin
21. The lipoprotein-associated coagulation inhibitor that inhibit the factor VII-tissue factor complex, also inhibits factor Xa: Insight into possible mechanism of action
22. Transient intermittent lymphocyte activation is responsible for instability of angina
23. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients
24. Quantitative coronary angiography: Estimation of dimensions, hemodynamic resistance and atheroma mass of coronary artery lesions using arteriogram and digital computation
25. Relationship between anticardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosus
26. Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-β2-glycoprotein I antibodies react in vitro with endothelial cells through adherent β2-glycoprotein I and induce endothelial activation
27. IgG antiendothelial cell antibodies from scleroderma induce leukocyte adhesion to human vascular endothelial cells in vitro
28. Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor
29. Simultaneous expression of tissue factor and tissue factor pathway inhibitor by human monocytes: A potential mechanism for localized control of blood coagulation
30. The spectrum of coronary artery pathologic findings in human cardiac allografts
31. Acute myocardial infarction in cardiac allograft recipients
32. Serologic characterization of Rocky Mountain spotted fever. Appearance of antibodies reactive with endothelial cells and phospholipids, and factors that alter protein C activation and prostacyclin secretion
33. Anti-endothelial cell antibodies in nephropathia epidemica and other viral diseases
34. Infectious agents and atherosclerotic vascular disease
35. Roles of infectious agents in atherosclerosis and restenosis: An assessment of the evidence and need for future research
36. Production of anti-endothelial cell antibodies by coculture of EBV infected human B cells with endothelial cells
37. Incidence and titers of antinuclear, antismooth muscle, and other autoantibodies in blood donors
38. Blood antiphospholipid antibody levels are influenced by age, sex and HLA-B8, DR3 phenotype
39. Antibodies to endothelial cells in borderline hypertension
40. Vascular endothelial cell antibodies in diabetic patients. Association with diabetic retinopathy
41. Acute T-cell activation is detectable in unstable angina
42. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina
43. Increased secretion of tumor necrosis factor-α and interferon-γ by mononuclear leukocytes in patients with ischaemic heart disease
44. Increased soluble form of P-selectin in patients with unstable angina
45. Elevated levels of circulating soluble adhesion molecules in peripheral blood of patients with unstable angina
46. Elevated serum lipoprotein(a) is a risk factor for clinical recurrence after coronary angioplasty
47. Is 40-70% diameter narrowing at the site of previous stenting or directional coronary ateroctomy clinically significant?
48. Lower expression of neutrophil adhesion molecule indicates less vessel wall injury and might explain lower restenosis rate after cutting baloon angioplasty
49. Inhibition of intimal hyperplasia after baloon injury by antibodies to intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1
50. Autoimmune and inflammatory responses may have an additive effect in postpercutaneous transluminal coronary angioplasty restenosis